NCT01261572View on ClinicalTrials.gov

Study to Find Maintenance Dose for Periodic Administration of ASP3550

PHASE2CompletedINTERVENTIONAL
Enrollment

155

Participants

Timeline

Start Date

October 12, 2010

Primary Completion Date

April 24, 2012

Study Completion Date

April 24, 2012

Conditions
Prostatic Neoplasms
Interventions
DRUG

degarelix

periodic injection

Trial Locations (8)

Unknown

Chugoku

Chūbu

Hokkaido

Kansai

Kantou

Kyusyu

Shuku

Tōhoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY